Allan Steven Jacobson is Director at PTC THERAPEUTICS, INC. (PTCT). They have made 5 open-market trades across 1 company since 2014, most recently 2026-01-02.
CIK 0001579003
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTCT | 21,451 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-01-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTCT | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $81.98 | $4.2M | -14.8% | -8.9% | -20.0% |
| PTCT | SELL · 10b5-1 | 2025-10-03 | 2025-10-07 | $65.00 | $780K | +2.1% | +12.4% | +18.8% |
| PTCT | SELL | 2025-08-28 | 2025-09-02 | $50.15 | $167K | +15.5% | +19.2% | +49.8% |
| PTCT | SELL | 2025-03-04 | 2025-03-06 | $51.52 | $127K | +4.8% | -19.1% | -3.4% |
| PTCT | SELL · 10b5-1 | 2024-01-22 | 2024-01-24 | $27.38 | $274K | -7.9% | -0.6% | -6.7% |
| PTCT | SELL · 10b5-1 | 2023-05-11 | 2023-05-12 | $54.94 | $2.3M | -14.6% | -21.2% | -26.1% |
| PTCT | SELL | 2020-11-04 | 2020-11-06 | $60.00 | $1.2M | +0.5% | -3.7% | +2.7% |
| PTCT | SELL | 2020-10-16 | 2020-10-20 | $51.29 | $256K | +2.3% | +23.2% | +28.7% |
| PTCT | SELL | 2020-04-17 | 2020-04-21 | $50.98 | $1.9M | -4.0% | -0.1% | +6.6% |
| PTCT | SELL · 10b5-1 | 2015-06-18 | 2015-06-19 | $50.13 | $251K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-03-18 | 2015-03-18 | $76.00 | $1.3M | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2014-09-18 | 2014-09-22 | $40.16 | $80K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2014-03-18 | 2014-03-19 | $31.18 | $237K | -28.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.